Searching map area
Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
Domenica Lorusso
Giovanni Scambia
Subject
phase II clinical trial
recurrent endometrial cancer
Doxorubicin
Endometrial cancer
References
Wikidata